David Michael Johnson - 03 Oct 2023 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Director
Signature
/s/ Julie Feder, Attorney-in-fact
Issuer symbol
AURA
Transactions as of
03 Oct 2023
Net transactions value
+$168,175
Form type
4
Filing time
05 Oct 2023, 19:56:36 UTC
Previous filing
16 Jun 2023
Next filing
09 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURA Common Stock Purchase $111,663 +13,500 +45% $8.27 43,500 03 Oct 2023 Direct F1
transaction AURA Common Stock Purchase $56,512 +6,566 +15% $8.61 50,066 04 Oct 2023 Direct F2
holding AURA Common Stock 139,672 03 Oct 2023 By Velocity Capital Management F3
holding AURA Common Stock 18,000 03 Oct 2023 By NEJ09 IRREVOCABLE TRUST F4
holding AURA Common Stock 18,000 03 Oct 2023 By NEJ12 IRREVOCABLE TRUST F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $8.00 to $8.51, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $8.52 to $8.66, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F3 Velosity Capital Management LLC is an entity that the reporting person is the sole member of.
F4 The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
F5 The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.